COMPANY

Nanopin Technologies, Inc.

HQ: New Orleans, LA source · nanopintech.com ↗ · Southeast

NanoPin's assays can ultimately be used for both HIV detection and the detection of TB in HIV patients. From company website Source · Oct 12, 2026

Keywords: assays Extrapulmonary Tuberculosis Pulmonary Tuberculosis Tuberculosis Active NanoDetect-TB

Location: New Orleans, LA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

2023-08 Trial start —: Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT05981495	Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease	Not listed	Unknown status (ClinicalTrials.gov)	2023-08	2024-12 (estimated)

Annual award amounts. Total $2.7M.

Jul 21, 2023 NIH award 5R44AI162527-03 FY2023: $685,056 awarded for that fiscal year; activity R44 (SBIR); PI TOMBLER, THOMAS W; recipient as written: NANOPIN TECHNOLOGIES, INC., New Orleans, LA. Early and accurate diagnosis of p source ↗
Jul 25, 2022 NIH award 5R44AI162527-02 FY2022: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI TOMBLER, THOMAS W; recipient as written: NANOPIN TECHNOLOGIES, INC., New Orleans, LA. Early and accurate diagnosis of source ↗
Aug 24, 2021 NIH award 1R44AI162527-01A1 FY2021: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI TOMBLER, THOMAS W; recipient as written: NANOPIN TECHNOLOGIES, INC., New Orleans, LA. Early and accurate diagnosis source ↗